Connor, Clark & Lunn Investment Management (CC&L)
RMD icon

Connor, Clark & Lunn Investment Management (CC&L)’s ResMed RMD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7M Buy
142,297
+113,034
+386% +$23.4M 0.05% 301
2026
Q1 		$6.57M Buy
+29,263
New +$7.29M 0.02% 603
2025
Q4 		– Sell
-84,120
Closed -$23M – 1750
2025
Q3 		$23M Sell
84,120
-40,125
-32% -$11M 0.07% 243
2025
Q2 		$32.1M Buy
124,245
+57,139
+85% +$13.6M 0.11% 159
2025
Q1 		$15M Buy
67,106
+5,166
+8% +$1.21M 0.07% 243
2024
Q4 		$14.2M Buy
61,940
+38,346
+163% +$9.23M 0.06% 238
2024
Q3 		$5.76M Buy
23,594
+19,184
+435% +$4.29M 0.03% 402
2024
Q2 		$844K Buy
4,410
+3,199
+264% +$649K ﹤0.01% 890
2024
Q1 		$240K Sell
1,211
-95,507
-99% -$17.5M ﹤0.01% 1347
2023
Q4 		$16.6M Sell
96,718
-126,292
-57% -$19.4M 0.08% 203
2023
Q3 		$33M Buy
223,010
+219,402
+6,081% +$39.7M 0.17% 113
2023
Q2 		$788K Buy
+3,608
New +$804K ﹤0.01% 865
2022
Q3 		– Sell
-1,023
Closed -$214K – 1229
2022
Q2 		$214K Sell
1,023
-662
-39% -$141K ﹤0.01% 922
2022
Q1 		$409K Buy
+1,685
New +$408K ﹤0.01% 818
2021
Q3 		– Sell
-14,030
Closed -$3.46M – 1197
2021
Q2 		$3.46M Sell
14,030
-8,888
-39% -$1.87M 0.02% 433
2021
Q1 		$4.45M Buy
22,918
+4,419
+24% +$886K 0.02% 384
2020
Q4 		$3.93M Buy
18,499
+3,835
+26% +$765K 0.02% 388
2020
Q3 		$2.51M Buy
+14,664
New +$2.71M 0.02% 434
2020
Q2 		– Sell
-14,593
Closed -$2.15M – 1156
2020
Q1 		$2.15M Buy
+14,593
New +$2.32M 0.02% 402
2018
Q3 		– Sell
-10,625
Closed -$1.1M – 1086
2018
Q2 		$1.1M Buy
+10,625
New +$1.08M 0.01% 592

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s RMD Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its ResMed (RMD) stake by 386% in Q2 2026, buying an estimated $23.4M and bringing the position to 142,297 shares worth $27.7M. The position accounts for 0.05% of the portfolio, ranked #301.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in RMD in Q2 2018 and has held it in 20 quarters since. The position peaked at $33M in Q3 2023. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 142,297 shares of ResMed worth $27.7M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 113,034 ResMed shares in Q2 2026, an estimated $23.4M.
  • ResMed made up 0.05% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #301 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ResMed in Q2 2018 and has held it in 20 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ResMed position peaked at $33M in Q3 2023.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.